Chemical Structure (Cyproheptadine Hydrochloride Tablets 1)
Cyproheptadine Hydrochloride Tablet
Product Images NDC 0115-1757
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 0115-1757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Cyproheptadine Hydrochloride Tablets 2)
This is a description of a medication containing Cyproheptadine hydrochloride, USP 4mg per tablet. It is advised to be stored at a temperature between 20-25°C (68-77°F) and dispensed in a tightly closed container as defined by USP. The tablets are manufactured and distributed by Amneal Pharmaceuticals LLC in Ahmedabad, India, and Bridgewater, NJ, respectively. It is recommended to use a child-resistant closure and keep the medication out of reach of children. The product's Mifg. Lic. No. is 6/25/2137.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
